Celyad Oncology Is A Clinical Stage Biotechnology Company Based In Mont Saint Guibertbelgiumwith Operations In New Yorknyfounded In 2007The Company Focuses On The Discovery And Development Of Chimeric Antigen Receptor T Cellcar Ttherapies For Cancerin June 2020It Rebranded To Better Align With Its Oncology Mission The Company Specializes In Next Generation Car T Cell Therapiesoffering Both Off The Shelf And Personalized Treatment Optionscelyad Oncology Utilizes Proprietary Technology Platforms To Develop Innovative Therapies Targeting A Wide Range Of Cancer Indicationsits Mission Is To Improve Lives By Addressing The Limitations Of Existing Car T Cell Therapies And Maximizing The Impact Of Its Candidate Treatmentscelyad Oncology Is Committed To Providing Solutions For Oncology Patients And Healthcare Providers Involved In Cancer Treatment
